These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 9974412)

  • 1. Tissue factor pathway inhibitor is expressed by human monocyte-derived macrophages : relationship to tissue factor induction by cholesterol and oxidized LDL.
    Petit L; Lesnik P; Dachet C; Moreau M; Chapman MJ
    Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):309-15. PubMed ID: 9974412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibronectin-adherent monocytes express tissue factor and tissue factor pathway inhibitor whereas endotoxin-stimulated monocytes primarily express tissue factor: physiologic and pathologic implications.
    Bajaj MS; Ghosh M; Bajaj SP
    J Thromb Haemost; 2007 Jul; 5(7):1493-9. PubMed ID: 17470199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of 17β-estradiol on cholesterol content in human macrophages is influenced by the lipoprotein milieu.
    Corcoran MP; Lichtenstein AH; Meydani M; Dillard A; Schaefer EJ; Lamon-Fava S
    J Mol Endocrinol; 2011 Aug; 47(1):109-117. PubMed ID: 21830321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of tissue factor and tissue factor pathway inhibitor with organ dysfunctions in septic shock.
    Lehner GF; Tobiasch AK; Perschinka F; Mayerhöfer T; Waditzer M; Haller V; Zassler B; Maier S; Ulmer H; Joannidis M
    Sci Rep; 2024 Jun; 14(1):14468. PubMed ID: 38914630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. lnc-MRGPRF-6:1 Promotes ox-LDL-Induced Macrophage Ferroptosis via Suppressing GPX4.
    You Z; Ye X; Jiang M; Gu N; Liang C
    Mediators Inflamm; 2023; 2023():5513245. PubMed ID: 37621767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of pig tissue factor pathway inhibitor α to increase anti-coagulation activity in pig-to-human xenotransplantation.
    Lee CH; Lee HJ; Park SW; Shin J; Kang SJ; Park IB; Kim HK; Chun T
    Biotechnol Lett; 2024 Aug; 46(4):521-530. PubMed ID: 38872071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A GPI-anchored co-receptor for tissue factor pathway inhibitor controls its intracellular trafficking and cell surface expression.
    Maroney SA; Cunningham AC; Ferrel J; Hu R; Haberichter S; Mansbach CM; Brodsky RA; Dietzen DJ; Mast AE
    J Thromb Haemost; 2006 May; 4(5):1114-24. PubMed ID: 16689766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmin enhances cell surface tissue factor activity in mesothelial and endothelial cells.
    Kothari H; Kaur G; Sahoo S; Idell S; Rao LV; Pendurthi U
    J Thromb Haemost; 2009 Jan; 7(1):121-31. PubMed ID: 18983492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased tissue factor pathway inhibitor activity is associated with myocardial infarction in young women: results from the RATIO study.
    Winckers K; Siegerink B; Duckers C; Maurissen LF; Tans G; Castoldi E; Spronk HM; Ten Cate H; Algra A; Hackeng TM; Rosendaal FR
    J Thromb Haemost; 2011 Nov; 9(11):2243-50. PubMed ID: 21895962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified LDL Particles Activate Inflammatory Pathways in Monocyte-derived Macrophages: Transcriptome Analysis.
    Orekhov AN; Oishi Y; Nikiforov NG; Zhelankin AV; Dubrovsky L; Sobenin IA; Kel A; Stelmashenko D; Makeev VJ; Foxx K; Jin X; Kruth HS; Bukrinsky M
    Curr Pharm Des; 2018; 24(26):3143-3151. PubMed ID: 30205792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of different anticoagulants on monocyte procoagulant functions and monocyte-platelet aggregates formation.
    Basavaraj MG; Østerud B; Hansen JB
    J Thromb Haemost; 2012 Aug; 10(8):1698-702. PubMed ID: 22712695
    [No Abstract]   [Full Text] [Related]  

  • 12. Tissue factor-heparanase complex: intracellular nonhemostatic effects.
    Ghanem S; Keren-Politansky A; Kaplan V; Crispel Y; Nadir Y
    Res Pract Thromb Haemost; 2023 Aug; 7(6):102179. PubMed ID: 37767062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cell-surface TFPIalpha and beta.
    Piro O; Broze GJ
    J Thromb Haemost; 2005 Dec; 3(12):2677-83. PubMed ID: 16246254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of copper sulfate-oxidized or myeloperoxidase-modified LDL on lipid loading and programmed cell death in macrophages under hypoxia.
    Vlaminck B; Calay D; Genin M; Sauvage A; Ninane N; Zouaoui Boudjeltia K; Raes M; Michiels C
    Hypoxia (Auckl); 2014; 2():153-169. PubMed ID: 27774474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No evidence for the presence of tissue factor in high-purity preparations of immunologically isolated eosinophils.
    Sovershaev MA; Lind KF; Devold H; Jørgensen TØ; Hansen JB; Østerud B; Egorina EM
    J Thromb Haemost; 2008 Oct; 6(10):1742-9. PubMed ID: 18665928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage fate: to kill or not to kill?
    Marrufo AM; Flores-Mireles AL
    Infect Immun; 2024 Sep; 92(9):e0047623. PubMed ID: 38829045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Tissue Factor Pathway in Cancer: Overview and Role of Heparan Sulfate Proteoglycans.
    Hassan N; Efing J; Kiesel L; Bendas G; Götte M
    Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown screening of chromatin binding and regulatory proteins in zebrafish identified Suz12b as a regulator of tfpia and an antithrombotic drug target.
    Raman R; Fallatah W; Al Qaryoute A; Dhinoja S; Jagadeeswaran P
    Sci Rep; 2021 Jul; 11(1):15238. PubMed ID: 34315984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel.
    Borén J; Chapman MJ; Krauss RM; Packard CJ; Bentzon JF; Binder CJ; Daemen MJ; Demer LL; Hegele RA; Nicholls SJ; Nordestgaard BG; Watts GF; Bruckert E; Fazio S; Ference BA; Graham I; Horton JD; Landmesser U; Laufs U; Masana L; Pasterkamp G; Raal FJ; Ray KK; Schunkert H; Taskinen MR; van de Sluis B; Wiklund O; Tokgozoglu L; Catapano AL; Ginsberg HN
    Eur Heart J; 2020 Jun; 41(24):2313-2330. PubMed ID: 32052833
    [No Abstract]   [Full Text] [Related]  

  • 20. Endogenous tissue factor pathway inhibitor in vascular smooth muscle cells inhibits arterial thrombosis.
    Yang J; Jin K; Xiao J; Ma J; Ma D
    Front Med; 2017 Sep; 11(3):403-409. PubMed ID: 28550640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.